can tirzepatide cause vision loss GLP-1 Drugs Loss? What the Research Says Comparative ocular outcomes of tirzepatide

10.2337/dc19-0295 [EL 1

A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse

Weeks 1-4: 1mg weekly (4mg total, small portion of first vial) Weeks 5-8: 2mg weekly (8mg total) Weeks 9-12: 4mg weekly (16mg total, finish first vial and start second) Weeks 13-16: 6mg weekly (24mg total, continue through second vial) Weeks 17-20: 8mg weekly (32mg total) Weeks 21-24: 8mg weekly maintenance (32mg total) Total peptide required: 116mg over 24 weeks Vials needed: 6 x 20mg vials with some remaining This protocol reaches 8mg maintenance by week 17 and holds there through week 24

Schedule Regular Follow-ups: Regular check-ins with your healthcare provider will ensure the new treatments effectiveness and allow for timely adjustments

At six months, the mean percentage change in body weight was -10.1% for those taking tirzepatide versus -5.8% for those taking semaglutide